Chimeric anti-CD20 monoclonal antibody (MabThera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study

M.H.J. van Oers; A. Hagenbeek; M. van Glabbeke; I. Teodorovic

Chimeric anti-CD20 monoclonal antibody (MabThera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study

Translated title of the contribution: Chimeric anti-CD20 monoclonal antibody (MabThera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study

M.H.J. van Oers, A. Hagenbeek, M. van Glabbeke, I. Teodorovic

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Chimeric anti-CD20 monoclonal antibody (MabThera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study
Original language	Undefined/Unknown
Pages (from-to)	553-557
Number of pages	5
Journal	Annals of Hematology
Volume	81
Publication status	Published - 2002

Cite this

@article{2617b486fda04df9b286067899222400,

title = "Chimeric anti-CD20 monoclonal antibody (MabThera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study",

author = "{van Oers}, M.H.J. and A. Hagenbeek and {van Glabbeke}, M. and I. Teodorovic",

year = "2002",

language = "Undefined/Unknown",

volume = "81",

pages = "553--557",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer-Verlag",

}

Chimeric anti-CD20 monoclonal antibody (MabThera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study. / van Oers, M.H.J.; Hagenbeek, A.; van Glabbeke, M. et al.
In: Annals of Hematology, Vol. 81, 2002, p. 553-557.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Chimeric anti-CD20 monoclonal antibody (MabThera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study

AU - van Oers, M.H.J.

AU - Hagenbeek, A.

AU - van Glabbeke, M.

AU - Teodorovic, I.

PY - 2002

Y1 - 2002

M3 - Article

SN - 0939-5555

VL - 81

SP - 553

EP - 557

JO - Annals of Hematology

JF - Annals of Hematology

ER -